Eli Lilly shares slip despite earnings beat By: CNBC.com News April 24, 2018 at 07:03 AM EDT A Food and Drug Administration advisory committee voted Monday against approving a higher dose of Lilly and Incyte's rheumatoid arthritis drug. Read More >> Related Stocks: Eli Lilly Incyte Corp